Search

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

The International Vaccine Institute’s Youngmi Cho is on a mission to protect communities against diseases of poverty

CellProthera is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction

Through a partnership with software developer Medable, Syneos Health aims to decentralize and personalize clinical trials.

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

We speak with Eric Dube, CEO of Travere Therapeutics, about his career and thoughts on leadership.

Industry experience needn’t always come post-academia – other options are available, as we learned in our chat with this Northern Irish PhD candidate

What are the societal impacts of rapid advances in the life science sector?

Can digital tools help cell and gene therapy evolve?

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza